ARLO

Arlo Technologies, Inc.
7 filings tracked
technologycloud computingSMALL ($300M-2B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Arlo Technologies has reached a critical financial inflection point, successfully transitioning from a hardware-centric vendor to a scalable, high-margin subscription business.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite the optimistic headline numbers, Arlo's underlying hardware business continues to struggle, acting as a persistent drag on overall profitability.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every ARLO filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing presents a company in the midst of a high-stakes transition. On one hand, the acceleration of subscription revenue and the move toward positive operating income suggest that Arlo's long-term strategy of monetizing its installed base is working. The shift in revenue mix toward high-margin services provides a clearer path to sustainable profitability than the company has ever had. However, the persistence of negative margins in the hardware segment and the heavy reliance on a single major customer create a precarious balance. Investors must weigh the excitement of the AI-driven healthcare expansion against the reality of a business that is still burning cash on its physical product line. The overall impact of the filing is a mixed signal: the growth engine is firing, but the structural weaknesses of the legacy hardware business remain unresolved.

Selected Quarter

Core Takeaway

Arlo is successfully shifting from a device seller to a service provider, though hardware remains a net loss center.

Investor Lens

Can the high-margin subscription growth outpace the structural losses of the hardware business and integration risks of new acquisitions?

Watch Next

Q2 2026 results to see if the Aloe Care Health integration delivers immediate revenue synergies.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.65Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bullishMay 7

Returned to operating profitability with $7.6M in income from operations.

earnings beat
80%
bullishMay 7

Consolidated gross margin increased to 48.3% from 44.3% YoY.

margin expansion
70%
bullishMay 7

Acquired Canary Connect and Aloe Care Health to expand AI and healthcare footprint.

acquisition
60%
bullishMay 7

Initiated $50M stock repurchase program with $8M already executed.

buyback
50%
bullishMay 7

Returned to operating profitability with $7.6M in income from operations.

earnings beat
80%
bullishMay 7

Consolidated gross margin increased to 48.3% from 44.3% YoY.

margin expansion
70%
bullishMay 7

Acquired Canary Connect and Aloe Care Health to expand AI and healthcare footprint.

acquisition
60%
bullishMay 7

Initiated $50M stock repurchase program with $8M already executed.

buyback
50%
bullishMay 7

Returned to operating profitability with $7.6M in income from operations.

earnings beat
80%
bullishMay 7

Consolidated gross margin increased to 48.3% from 44.3% YoY.

margin expansion
70%
bullishMay 7

Acquired Canary Connect and Aloe Care Health to expand AI and healthcare footprint.

acquisition
60%
bullishMay 7

Initiated $50M stock repurchase program with $8M already executed.

buyback
50%
bullishMay 7

Returned to operating profitability with $7.6M in income from operations.

earnings beat
80%
bullishMay 7

Consolidated gross margin increased to 48.3% from 44.3% YoY.

margin expansion
70%
bullishMay 7

Acquired Canary Connect and Aloe Care Health to expand AI and healthcare footprint.

acquisition
60%
bullishMay 7

Initiated $50M stock repurchase program with $8M already executed.

buyback
50%
bullishMay 7

Returned to operating profitability with $7.6M in income from operations.

earnings beat
80%
bullishMay 7

Consolidated gross margin increased to 48.3% from 44.3% YoY.

margin expansion
70%
bullishMay 7

Acquired Canary Connect and Aloe Care Health to expand AI and healthcare footprint.

acquisition
60%
bullishMay 7

Initiated $50M stock repurchase program with $8M already executed.

buyback
50%
bullishMay 7

Returned to operating profitability with $7.6M in income from operations.

earnings beat
80%
bullishMay 7

Consolidated gross margin increased to 48.3% from 44.3% YoY.

margin expansion
70%
bullishMay 7

Acquired Canary Connect and Aloe Care Health to expand AI and healthcare footprint.

acquisition
60%
bullishMay 7

Initiated $50M stock repurchase program with $8M already executed.

buyback
50%
bullishMay 7

Returned to operating profitability with $7.6M in income from operations.

earnings beat
80%
bullishMay 7

Consolidated gross margin increased to 48.3% from 44.3% YoY.

margin expansion
70%
bullishMay 7

Acquired Canary Connect and Aloe Care Health to expand AI and healthcare footprint.

acquisition
60%
bullishMay 7

Initiated $50M stock repurchase program with $8M already executed.

buyback
50%

Filing History

10-QMay 7, 2026
Expand Sequence

The Q1 2026 filing presents a company in the midst of a high-stakes transition. On one hand, the acceleration of subscription revenue and the move toward positive operating income suggest that Arlo's long-term strategy of monetizing its installed base is working. The shift in revenue mix toward high-margin services provides a clearer path to sustainable profitability than the company has ever had. However, the persistence of negative margins in the hardware segment and the heavy reliance on a single major customer create a precarious balance. Investors must weigh the excitement of the AI-driven healthcare expansion against the reality of a business that is still burning cash on its physical product line. The overall impact of the filing is a mixed signal: the growth engine is firing, but the structural weaknesses of the legacy hardware business remain unresolved.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.